Import trade restrictions for 3006400000 80
This table contains information on trade restrictions for the import of goods into the EU and the EU into third countries. The table contains information on trade restrictions which are imposed due to customs unions, preferences, tariff quotas, customs unions, veterinary controls, third country duties and non-preferential tariff quotas.
| Origin country | Start | Duty / Tax | Legal base Measure type | |
|---|---|---|---|---|
1011 | ERGA OMNES 1011 | 01-01-2002 | 0 % | Third country duty 103 |
| Faroe Islands FO | 01-01-1997 | 0 % | Tariff preference 142 | |
XL | Melilla XL | 01-01-1999 | 0 % | Accession act0001/85 Tariff preference 142 |
| San Marino SM | 01-01-2006 | 0 % | Customs union duty 106 | |
| Türkiye TR | 01-01-2006 | 0 % | Customs union duty 106 | |
| Andorra AD | 01-01-2006 | 0 % | Customs union duty 106 | |
| EU-Switzerland agreement: re-imported goods 1007 | 01-01-2007 | 0 % | Tariff preference 142 | |
| United Kingdom GB | 01-01-2021 | 0 % | Tariff preference 142 | |
2080 | OCTs (Overseas Countries and Territories) 2080 | 01-01-2021 | 0 % | Tariff preference 142 |
| Tunisia TN | 01-03-1998 | 0 % | Tariff preference 142 | |
| Morocco MA | 01-03-2000 | 0 % | Tariff preference 142 | |
| Lebanon LB | 01-04-2006 | 0 % | Tariff preference 142 | |
| Jordan JO | 01-05-2002 | 0 % | Tariff preference 142 | |
XC | Ceuta XC | 01-07-1991 | 0 % | Accession act0001/85 Tariff preference 142 |
| United States US | 01-07-2026 | 0 % | Tariff preference 142 | |
| Syria SY | 01-08-1994 | 0 % | Tariff preference 142 | |
| Algeria DZ | 01-09-2005 | 0 % | Tariff preference 142 | |
1011 | ERGA OMNES 1011 | 01-11-2026 | 2 EUR | Union handling fee 800 |
1011 | ERGA OMNES 1011 | 01-11-2026 | 3 EUR | Low-value consignment customs duty 107 |
2000 | Preferential origin in accordance with the Agreement in the form of an Exchange of Letters between the European Union and the Kingdom of Morocco on the amendment of Protocols 1 and 4 to the Euro-Mediterranean Agreement establishing an association between the European Communities and their Member States, of the one part, and the Kingdom of Morocco, of the other part. 2000 | 03-10-2025 | 0 % | Tariff preference 142 |
| Israel IL | 16-05-2023 | 0 % | Tariff preference 142 | |
| Switzerland CH | 25-10-2000 | 0 % | Tariff preference 142 |
| Origin country | Start | Duty / Tax | Legal base Measure type | |
|---|---|---|---|---|
1008 | All third countries 1008 | 01-07-2026 | Document required banned without it | Import control of mercury 748 |
1011 | ERGA OMNES 1011 | 10-02-2023 | Document required banned without it | Import control on REACH 761 |
| Ukraine UA | 24-06-2026 | Document required banned without it | Import control 762 | |
| Ukraine UA | 24-06-2026 | Document required banned without it | Import control 760 |
Explanation of trade restrictions
Erga Omnes means "for all".
Third countries are countries that are not part of the EU.
GSP means "Generalised System of Preferences".
GSP Plus means "Generalised System of Preferences Plus".
European Economic Area (EEA) means all EU member states and Iceland, Liechtenstein and Norway.
OCTs stands for "Overseas Countries and Territories". They are countries and territories that are not part of the EU. More information
CARIFORUM is a regional economic integration organisation comprising 15 Caribbean Community (CARICOM) countries and the Dominican Republic.
SADC EPA stands for "Southern African Development Community - Economic Partnership Agreement".
Duty means "customs duties".
Estimate the import cost for 300640
An estimate only. The customs value is the price including transport and insurance to the EU border. Excise duties, other fees and producer-specific anti-dumping rates are not included. Preferential rates need valid proof of origin. Country groups and exclusions: TARIC, as of November 2026.
Export measures for 3006400000
What applies when these goods leave the EU: export controls, dual-use and other authorisations, bans per destination and the supplementary unit of the export declaration.
| Destination | Start | Duty / Tax | Legal base Measure type | |
|---|---|---|---|---|
1008 | All third countries 1008 | 01-01-2025 | Document required banned without it | Export control of mercury 749 |
History
Duty rates and measures for this code over time (yearly snapshots).
Preferential rules of origin for 3006400000
What the goods must meet to count as originating in a partner country and get the preferential duty, per agreement.
EU-Egypt Association Agreement · Egypt
EU-Jordan Association Agreement · Jordan
EU-Lebanon Association Agreement · Lebanon
EU-Morocco Association Agreement · Morocco
EU-Tunisia Association Agreement · Tunisia
Waste pharmaceuticals specified in note 4(k) to this Chapter / or: The origin of the product in its original classification shall be retained
EPA CARIFORUM
EU Market Access Regulation (EPA) · Cameroon, Côte d’Ivoire, Ghana, Kenya
EU-Mexico Global Agreement · Mexico
Pharmaceutical products; except for: / or: Manufacture in which all the materials used are classified within a heading other than that of the product. However, materials classified within the same heading may be used provided their value does not exceed 20 % of the ex-works price of the product
EU-Chile Association Agreement · Chile
EU-Algeria Association Agreement · Algeria
Waste pharmaceuticals specified in note 4(k) to this chapter / or: The origin of the product in its original classification shall be retained
EU-Georgia DCFTA · Georgia
EU-Moldova DCFTA · Moldova
— Waste pharmaceuticals specified in note 4(k) to this Chapter / or: The origin of the product in its original classification shall be retained — Sterile surgical or dental adhesion barriers, whether or not absorbable:
Generalised Scheme of Preferences (GSP, GSP+, EBA) · Armenia, India, Kenya, Pakistan, Samoa, Solomon Islands, Syria, Vietnam
EU-Singapore FTA · Singapore
Pharmaceutical products / or: Manufacture from materials of any heading
Autonomous Trade Preferences (Western Balkans) · Kosovo
Waste pharmaceuticals specified in note 4(k) to Chapter 30 / or: The origin of the product in its original classification shall be retained
EU-Canada CETA · Canada
A change from within any one of these subheadings or any other subheading.
EU-Colombia/Peru/Ecuador Trade Agreement · Colombia, Ecuador, Peru
Waste pharmaceuticals specified in note 4(k) to this Chapter / or: The origin of the product in its original classification shall be retained
Sterile surgical or dental adhesion barriers, whether or not absorbable:
made of plastics / or: Manufacture in which the value of all the materials of Chapter 39 used does not exceed 20 per cent of the ex-works price of the product / or: Manufacture in which the value of all the materials used does not exceed 25 per cent of the ex-works price of the product
made of fabrics / or: Manufacture from [17] : natural fibres man-made staple fibres, not carded or combed or otherwise processed for spinning, or chemical materials or textile pulp
appliances identifiable for ostomy use / or: Manufacture in which the value of all the materials used does not exceed 50 per cent of the ex-works price of the product [17] For special conditions relating to products made of a mixture of textile materials, see Introductory Note 5 .
EU-Japan EPA · Japan
CTSH; A chemical reaction, purification, mixing and blending, production of standard materials, a change in particle size, isomer separation or biotechnological processing is undergone; MaxNOM 50 % (EXW); or RVC 55 % (FOB).
EU-Korea FTA · South Korea
Pharmaceutical products; except for: / or: Manufacture from materials of any heading, except that of the product. However, materials of the same heading as the product may be used, provided that their total value does not exceed 20 % of the ex-works price of the product
EU-Central America Association Agreement
— Waste pharmaceuticals specified in note 4(k) to this Chapter / or: The origin of the product in its original classification shall be retained
— Sterile surgical or dental adhesion barriers, whether or not absorbable:
Pan-Euro-Mediterranean (PEM) Convention · Albania, Andorra, Bosnia & Herzegovina, Egypt, Faroe Islands, Iceland, Kosovo, Liechtenstein, Montenegro, North Macedonia, Norway, Palestine, Switzerland, Türkiye
– Waste pharmaceuticals specified in note 4(k) to this Chapter / or: The origin of the product in its original classification shall be retained
– Sterile surgical or dental adhesion barriers, whether or not absorbable:
– – made of plastics / or: Manufacture in which the value of all the materials of Chapter 39 used does not exceed 20 % of the ex-works price of the product [10] / or: Manufacture in which the value of all the materials used does not exceed 25 % of the ex-works price of the product
– – made of fabrics / or: Manufacture from [11] : natural fibres man-made staple fibres, not carded or combed or otherwise processed for spinning, or chemical materials or textile pulp
– Appliances identifiable for ostomy use / or: Manufacture in which the value of all the materials used does not exceed 50 % of the ex-works price of the product [10] In the case of the products composed of materials classified within both headings 3901 to 3906, on the one hand, and within heading 3907 to 3911, on the other hand, this restriction only applies to that group of materials which predominates by weight in the product. / or: [11] For special conditions relating to products made of a mixture of textile materials, see Introductory Note 5 .
EU-Palestine Interim Association Agreement · Palestine
Pharmaceutical products; except for: / or: Manufacture in which all the materials used are classified within a heading other than that of the product. However, materials classified within the same heading may be used provided their value does not exceed 20% of the ex-works price of the product
EU-Ukraine DCFTA · Ukraine
– Waste pharmaceuticals specified in note 4(k) to this Chapter / or: The origin of the product in its original classification shall be retained
– Sterile surgical or dental adhesion barriers, whether or not absorbable:
EU-Viet Nam FTA · Vietnam
Pharmaceutical products. / or: Manufacture from materials of any heading.
Source: European Commission, Access2Markets (CC BY 4.0, shortened). The text of the agreement prevails. Access2Markets
Legal and explanatory notes for 3006400000
Notes to chapter 30
Notes 1. This chapter does not cover: (a) foods or beverages (such as dietetic, diabetic or fortified foods, food supplements, tonic beverages and mineral waters), other than nutritional preparations for intravenous administration (Section IV); (b) products, such as tablets, chewing gum or patches (transdermal systems), containing nicotine and intended to assist tobacco use cessation (heading 2404); (c) plasters specially calcined or finely ground for use in dentistry (heading 2520); (d) aqueous distillates or aqueous solutions of essential oils, suitable for medicinal uses (heading 3301); (e) preparations of headings 3303 to 3307, even if they have therapeutic or prophylactic properties; (f) soap or other products of heading 3401 containing added medicaments; (g) preparations with a basis of plaster for use in dentistry (heading 3407); (h) blood albumin not prepared for therapeutic or prophylactic uses (heading 3502); or (ij) diagnostic reagents of heading 3822. 2. For the purposes of heading 3002, the expression ‘immunological products’ applies to peptides and proteins (other than goods of heading 2937) which are directly involved in the regulation of immunological processes, such as monoclonal antibodies (MAB), antibody fragments, antibody conjugates and antibody fragment conjugates, interleukins, interferons (IFN), chemokines and certain tumour-necrosis factors (TNF), growth factors (GF), hematopoietins and colony-stimulating factors (CSF). 3. For the purposes of headings 3003 and 3004 and of note 4(d) to this chapter, the following are to be treated: (a) as unmixed products: (1) unmixed products dissolved in water; (2) all goods of Chapter 28 or 29; and (3) simple vegetable extracts of heading 1302, merely standardised or dissolved in any solvent; (b) as products which have been mixed: (1) colloidal solutions and suspensions (other than colloidal sulphur); (2) vegetable extracts obtained by the treatment of mixtures of vegetable materials; and (3) salts and concentrates obtained by evaporating natural mineral waters. 4. Heading 3006 applies only to the following, which are to be classified in that heading and in no other heading of the nomenclature: (a) sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; (b) sterile laminaria and sterile laminaria tents; (c) sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable; (d) opacifying preparations for X-ray examinations and diagnostic reagents designed to be administered to the patient, being unmixed products put up in measured doses or products consisting of two or more ingredients which have been mixed together for such uses; (e) placebos and blinded (or double-blinded) clinical trial kits for use in recognised clinical trials, put up in measured doses, even if they might contain active medicaments; (f) dental cements and other dental fillings; bone reconstruction cements; (g) first-aid boxes and kits; (h) chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides; (ij) gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments; (k) waste pharmaceuticals, that is, pharmaceutical products which are unfit for their original intended purpose due to, for example, expiry of shelf life; and (l) appliances identifiable for ostomy use, that is, colostomy, ileostomy and urostomy pouches cut to shape and their adhesive wafers or faceplates. Subheading notes 1. For the purposes of subheadings 3002 13 and 3002 14, the following are to be treated: (a) as unmixed products, pure products, whether or not containing impurities; (b) as products which have been mixed: (1) the products mentioned in (a) above dissolved in water or in other solvents; (2) the products mentioned in (a) and (b) (1) above with an added stabiliser necessary for their preservation or transport; and (3) The products mentioned in (a), (b) (1) and (b) (2) above with any other additive. 2. Subheadings 3003 60 and 3004 60 cover medicaments containing artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or containing any of the following active principles, whether or not combined with other pharmaceutical active ingredients : amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN). Additional note 1. Heading 3004 includes herbal medicinal preparations and preparations based on the following active substances: vitamins, minerals, essential amino-acids or fatty acids, in packings for retail sale. These preparations are classified in heading 3004 if they bear on the label, packaging or on the accompanying user directions the following statements of: (a) the specific diseases, ailments or their symptoms for which the product is to be used; (b) the concentration of active substance or substances contained therein; (c) dosage; and (d) mode of application. This heading includes homeopathic medicinal preparations when they meet the conditions of (a), (c) and (d) mentioned above. In the case of preparations based on vitamins, minerals, essential amino-acids or fatty acids, the level of one of these substances per recommended daily dose indicated on the label must be significantly higher than the recommended daily allowance to maintain general health or well-being.
Other explanatory notes for the chapter
Additional note 1 1. Herbal medicinal preparations are preparations based on one or more active substances, produced by subjecting a plant or parts thereof to a process such as drying, crushing, extraction or purification. Active substance means a chemically defined substance, a chemically defined group of substances (for example, alkaloids, polyphenols, anthocyanins) or a plant extract. These active substances must have medicinal properties for the prevention or the treatment of specific diseases, ailments or their symptoms. 2. Homeopathic medicinal preparations are prepared from products, substances or compositions called homeopathic stocks (mother tinctures). The degree of dilution must be indicated (for example, D6). 3. Vitamins or mineral preparations are preparations based on vitamins of heading 2936, on minerals including trace elements and mixtures thereof. They are used to treat or prevent specific diseases, ailments or their symptoms. Such preparations contain a much higher amount of vitamins or minerals, generally at least three times higher than the recommended daily allowance (RDA). As regards the recommended daily allowance (RDA) for certain vitamins and minerals, see, for example, the table in the Annex XIII to Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food information to consumers (OJ L 304, 22.11.2011, p. 58) reproduced below: Vitamins and minerals | RDA Vitamin A | 800 μg Vitamin D | 5 μg Vitamin E | 12 mg Vitamin K | 75 μg Vitamin C | 80 mg Thiamin 1,1 mg Riboflavin | 1,4 mg Niacin 16 mg Vitamin B6 | 1,4 mg Folic acid | 200 μg Vitamin B12 | 2,5 μg Biotin 50 μg Pantothenic acid | 6 mg Potassium | 2 000 mg Chloride 800 mg Calcium 800 mg Phosphorus | 700 mg Magnesium | 375 mg Iron 14 mg Zinc 10 mg Copper 1 mg Manganese | 2 mg Fluoride 3,5 mg Selenium 55 μg Chromium 40 μg Molybdenum | 50 μg Iodine 150 μg 4. Recommended daily allowance (RDA) for adults with a weight of 70 kg, on essential amino acids, according to the joint WHO/FAO/UNU expert Consultation 2007: Essential Amino Acid | RDA (mg) Histidine | 700 Isoleucine | 1 400 Leucine 2 730 Lysine 2 100 Methionine + Cysteine | 1 050 Cysteine 287 Methionine | 728 Phenylalanine + Tyrosine | 1 750 Threonine | 1 050 Tryptophan | 280 Valine 1 820 Recommended daily allowance (RDA) for adults with a weight of 70 kg, on essential fatty acids, according to the joint WHO/FAO/UNU expert Consultation 2007. Types of essential fatty acids | Name of essential fatty acid | RDA (g) n-3 polyunsaturated fatty acids | linolenic acid (ALA) | 2 long-chain n-3 polyunsaturated fatty acids | EPA plus DHA | 0,25 n-6 polyunsaturated fatty acids | linoleic acid | 10
Sources: Combined Nomenclature 2026, Annex I to Regulation (EEC) No 2658/87 (CELEX 32025R1926), and the Explanatory Notes to the Combined Nomenclature (CELEX 02019XC0329(02)-20260213). The section and chapter notes are legally binding; the explanatory notes are guidance. EUR-Lex
EU classification regulations for 3006400000
Commission regulations that classified specific goods under this code. They bind customs in every member state for identical goods.
- 3006 40 00 Apr 1, 2022 · Regulation on EUR-Lex
A set described as a “composite system for dental repair” put up for retail sale in a carton box in which all the elements are presented together with an instruction for use.
The set is composed of:
Reasons
Classification is determined by general rules 1, 3 (b) and 6 for the interpretation of the Combined Nomenclature, note 4 (f) to Chapter 30 and the wording of CN codes 3006 and 3006 40 00 . Classification under heading 9021 is excluded, as the product is not a prefabricated product (such as a crown) that resemble in appearance any defective part of the body (see also the Harmonized System Explanatory Note to heading 9021 , Section III, first paragraph and Part (B), point (4) and the first sentence of the second subparagraph). The composite materials filled in syringes are the components that give the set its essential character. They can be used in dentistry as dental fillings, which are covered by heading 3006 (note 4 (f) to Chapter 30, see also the above mentioned Harmonized System Explanatory Note to heading 9021 , Section III, Part (B), second subparagraph, first sentence). Classification under heading 3824 and under heading 3906 is excluded as the product is more specifically covered by the wording of Note 4 (f) to Chapter 30, as a dental filling. Consequently, the product is to be classified in CN code 3006 40 00 as other dental fillings.
- 3006 40 00 Sep 11, 2014 · Regulation on EUR-Lex
A liquid product consisting of a silane, MDP phosphate monomer, dimethacrylate resins, 2-hydroxyethyl-methacrylate (HEMA), a copolymer, filler, ethanol, water and initiators. It is intended for dental use.
The product prepares the surface of tooth cavities for bonding with filling material. It can also be used for root desensitisation, for sealing of dentine prior to cementation of amalgam restorations, as protective coating for glass ionomer restorative materials or for bonding of pit and fissure sealants.
Reasons
Classification is determined by the general rules 1, 3(a) and 6 for the interpretation of the Combined Nomenclature, note 4(f) to Chapter 30 and the wording of CN codes 3006 and 3006 40 00 . Given its objective characteristics, namely the presence of ethanol and water, the product is more fluid than a traditional filler and capable of easily infiltrating into the tooth. Although the product has the appearance of an adhesive, its use is that of a primer on teeth, in order to activate the dentine on the surface for bonding with the filling material. The product remains on the tooth during and after the treatment and becomes an integral part of the filling. Classification under heading 3506 as glue is excluded as heading 3006 provides the more specific description. In addition, some of the intended uses (root desensitisation, sealing of dentine and use as protective coating) are not typical of glue. The product is therefore to be classified under CN code 3006 40 00 as dental cements and other dental fillings.
UK advance tariff rulings for 3006400000
Rulings of HM Revenue & Customs for goods with UK commodity codes that start like this EU code. The UK tariff differs from the EU tariff, so these rulings are guidance for the EU.
- UK 3006400000 Valid Aug 5, 2025 to Aug 4, 2028 · Ruling 600013441 on GOV.UK
The product is a dental powder preparation used to restore, replace, fill in damaged or missing teeth. Made from silicon dioxide, aluminium dioxide, potassium dioxide, sodium carbonate and zirconium dioxide. Mixed with a liquid. The mix is modelled into the shape of a tooth and then fired in a furnace, where it is hardened to produce a ceramic prosthesis. The product is packaged in plastic bottles of various sizes.
Justification
Classification has been determined in accordance with the following: For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)s: GIR 1 has been used to classify this product by the terms of heading 3006 - Pharmaceutical goods specified in note 4 to this chapter GIR 5B has been used to identify the type of packaging: plastic bottles GIR 6 has been used to classify this product by the terms of heading 300640 -Dental cements and other dental fillings; bone reconstruction cements Also classified in accordance with: Note 4(f) to Chapter 30 Harmonised System Explanatory Notes to heading 3006
Source: HM Revenue & Customs, Advance Tariff Rulings. Contains public sector information licensed under the Open Government Licence v3.0.
EU trade in 2025 for 300640
- Extra-EU imports
- €524.6M
- 1,260 t
- Extra-EU exports
- €1B
Top origin countries by import value
Liechtenstein €216.2M
Japan €115.6M
United States €101.4M
United Kingdom €22.8M
South Korea €17M
CN8 codes below this code: 1. Source: Eurostat, Comext, CC BY 4.0, processed by hscode.info. Confidential trade is not allocated to codes.
UK import duty for 300640
- 0%
Third-country duties of all UK commodity codes under this HS subheading. Source: UK Department for Business and Trade, as of Nov 2, 2026. The UK tariff differs from the EU tariff.
Import VAT in the EU
- Austria 20 %
- Belgium 21 % maybe 6 %
- Bulgaria 20 %
- Croatia 25 % maybe 5 %
- Cyprus 19 % maybe 5 %
- Czechia 21 % maybe 12 %
- Denmark 25 %
- Estonia 24 %
- Finland 25.5 %
- France 20 %
- Germany 19 %
- Greece 24 % maybe 6 %, 13 %
- Hungary 27 %
- Ireland 23 %
- Italy 22 %
- Latvia 21 % maybe 12 %
- Lithuania 21 % maybe 5 %
- Luxembourg 17 % maybe 3 %
- Malta 18 % maybe 5 %
- Netherlands 21 % maybe 9 %
- Poland 23 %
- Portugal 23 % maybe 6 %
- Romania 21 % maybe 11 %
- Slovakia 23 % maybe 5 %
- Slovenia 22 % maybe 9.5 %
- Spain 21 % maybe 10 %
- Sweden 25 %
Standard rate per member state, on the customs value, the duty and transport to the destination. Reduced rates often depend on the use or the buyer and apply only where the country provides them for these goods. Source: European Commission, Taxes in Europe Database, as of Nov 2, 2026.
Rules of origin
Preferential rules of origin for subheading 300640 depend on the trade agreement. The Commission publishes them in Access2Markets.
Rules of origin on Access2MarketsInformation
When importing or exporting "Dental cements and other dental fillings; bone reconstruction cements", it is crucial to have the correct HS code or TARIC code. The HS code 3006400000 80 serves as the standard code for this product, ensuring that the appropriate duties and taxes are applied when crossing international borders.
To ensure your business transactions run smoothly when importing or exporting "Dental cements and other dental fillings; bone reconstruction cements", consider the following points:
- Inform yourself about the specific import and export regulations in the countries involved. This includes possible restrictions, taxes, and duties applicable to "Dental cements and other dental fillings; bone reconstruction cements".
- Check if any additional licenses, permits, or certificates are required to import "Dental cements and other dental fillings; bone reconstruction cements" into the destination country or export it from the country of origin.
- Make sure your trading partners have valid identification numbers, such as EORI numbers (Economic Operators Registration and Identification) in the EU, to streamline trade and minimize delays.
- Ensure that all trade- and customs-related documents (such as commercial invoices, packing lists, certificates of origin, and insurance policies) are accurately completed and adhere to the respective national regulations.
- Keep an eye on the current exchange rates, as well as packaging, shipping, and insurance costs, to accurately calculate trade costs.
In summary, the HS code or TARIC code for "Dental cements and other dental fillings; bone reconstruction cements" is 3006400000 80. Make sure you accurately use this code in all your trade and customs documents to guarantee smooth and hassle-free transactions. With these tips, you'll be better prepared for the challenges of international trade and can successfully import and export "Dental cements and other dental fillings; bone reconstruction cements".
HS Code structure
1. Chapter
There are 21 different sections, which are divided into 96 chapters. Exceptional chapters include chapter 77, which is reserved for future use, chapters 98 and 99, which are limited at national level, and chapter 99, which is a specific code for temporary changes. In the example above, chapter 30 was selected for pharmaceutical products
2. Heading
The heading determines the specific category within a certain chapter. In the example above, the 06 refers to Pharmaceutical goods specified in note 4 to this chapter.
3. Subheading
The last two digits of the international harmonized code are more specific and define subcategories of products. In the example above, the 40 refers to Dental cements and other dental fillings; bone reconstruction cements.
HS Code tree structure
3000000000 80
Chapter PHARMACEUTICAL PRODUCTS
3006000000 80
Pharmaceutical goods specified in note 4 to this chapter
3006100000 80
- Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable
3006101000 80
- - Sterile surgical catgut
3006103000 80
- - Sterile surgical or dental adhesion barriers, whether or not absorbable
3006109000 80
- - Other
3006300000 80
- Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient
3006400000 80
- Dental cements and other dental fillings; bone reconstruction cements
3006500000 80
- First-aid boxes and kits
3006600000 80
- Chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides
3006700000 80
- Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments
3006910000 10
- Other
3006910000 80
- - Appliances identifiable for ostomy use
3006920000 80
- - Waste pharmaceuticals
3006930000 80
- - Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses